Idiopathic multicentric Castleman's disease: a systematic literature review.
Liu AY, Nabel CS, Finkelman BS, Ruth JR, Kurzrock R, van Rhee F, Krymskaya VP, Kelleher D, Rubenstein AH, Fajgenbaum DC.
Lancet Haematol. 2016 Apr;3(4):e163-75. doi: 10.1016/S2352-3026(16)00006-5. Epub 2016 Mar 17.
Castleman's disease, pathophysiology, advances in diagnosis and treatment.
Pertusa Mataix R, Loaiza Cabello D, García Morillo JS.
Med Clin (Barc). 2024 Mar 22;162(6):283-290. doi: 10.1016/j.medcli.2023.10.013. Epub 2023 Nov 27.
Idiopathic multicentric Castleman disease: An update in diagnosis and treatment advances.
Lang E, van Rhee F.
Blood Rev. 2024 Mar;64:101161. doi: 10.1016/j.blre.2023.101161. Epub 2023 Dec 5.
Angiofollicular lymph node hyperplasia (Castleman's disease).
McCarty MJ, Vukelja SJ, Banks PM, Weiss RB.
Cancer Treat Rev. 1995 Jul;21(4):291-310. doi: 10.1016/0305-7372(95)90034-9.
Osteosclerosis in Castleman's disease.
Liu SZ, Zhou X, Wang YP, Liu Y.
QJM. 2022 Mar 22;115(3):171-172. doi: 10.1093/qjmed/hcac013.
[Castleman's disease].
Larroche C, Cacoub P, Godeau P.
Rev Med Interne. 1996;17(12):1003-13. doi: 10.1016/s0248-8663(97)80844-2.
La maladie de Castleman : aspects anatomopathologiques.
Meignin V, Parrens M.
Rev Med Interne. 2022 Dec;43(10S1):10S10-10S16. doi: 10.1016/S0248-8663(23)00020-6.
Non-Clonal Lymphoproliferative Diseases.
Dirnhofer S, Nishimura Y, Dispenzieri A.
Hematol Oncol. 2025 Jun;43 Suppl 2:e70065. doi: 10.1002/hon.70065.
Castleman's disease: one disease, multiple etiologies.
Esteban-Sampedro J, Martín-Portugués M, Campo PD, Fernández-Güitián R, Ruiz-Becerra JE, Moreno-Torres V.
AIDS Rev. 2024;26(4):158-172. doi: 10.24875/AIDSRev.M25000079.
Mesenteric Castleman's disease.
Kim SH, Min BW, Kim WB, Park SS, Um JW, Lee JB, Mok YJ, Choi SY, Moon HY, Koo BH, Lee JH, Kim IS.
Yonsei Med J. 2005 Apr 30;46(2):289-91. doi: 10.3349/ymj.2005.46.2.289.
